Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 17, 2007
J Am Soc Nephrol 18: 646-653, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006050433

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006050433v1
18/2/646    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fink, J. C.
Right arrow Articles by Seliger, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fink, J. C.
Right arrow Articles by Seliger, S. L.

Clinical Dialysis

Center Effects in Anemia Management of Dialysis Patients

Jeffrey C. Fink*,{dagger}, Van Doren Hsu{ddagger}, Min Zhan{dagger}, Lori D. Walker{ddagger}, C. Daniel Mullins{ddagger}, Charlotte Jones-Burton*, Patricia Langenberg{dagger} and Stephen L. Seliger*,{dagger}

Departments of * Medicine and {dagger} Epidemiology and Preventive Medicine, University of Maryland School of Medicine, and {ddagger} Pharmaceutical Research Computing, University of Maryland School of Pharmacy, Baltimore, Maryland

Address correspondence to: Dr. Jeffrey C. Fink, Room N3W143, 22 S. Greene Street, University of Maryland Medical System, Baltimore, MD 21201. Phone: 410-328-5720; Fax: 410-328-5685; E-mail: jfink{at}medicine.umaryland.edu

Received for publication May 4, 2006. Accepted for publication December 5, 2006.

This study set out to determine whether there is a center effect on anemia management in hemodialysis patients. The US Renal Data System and Medicare standard analysis files were analyzed. Between-center variation and within-facility correlations in hematocrit values were examined in two separate data sets (years 2000 and 2001) and compared with simulated samples that were composed of random values that assumed no center effect. Mixed-effect models were used to adjust for multiple factors and quantify the within-facility correlation in hematocrit values. Expected hematocrit values were compared in patients who underwent dialysis at poor and superior performing facilities with fixed characteristics including epoetin {alpha} dosing. There was a wider center variation in hematocrit for the actual versus simulated data and a coefficient of variation of 4.1% for the former versus 1.7% for the latter, in both years. The within-facility correlation for hematocrit was 0.053 (95% confidence interval 0.050 to 0.056; P < 0.001) in 2000 with similar values in 2001 but no within-facility correlation in the simulated data. The impact of these findings was demonstrated with a difference in expected hematocrit for a patient who was treated with fixed-dosage epoetin {alpha} in the poorest versus best performing units (mean difference in expected hematocrit 3.06; 95% confidence interval 3.03 to 3.09; P < 0.001). Key attributes of a center effect on anemia management in hemodialysis have been identified. The presence of a center effect suggests that there are facility-specific processes that influence performance in dialysis anemia management and are independent of commonly titrated inputs, such as dosing of erythropoietic agents.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
K. E. Chan, R. A. Lafayette, A. S. Whittemore, M. A. Hlatky, and J. Moran
Facility factors dominate the ability to achieve target haemoglobin levels in haemodialysis patients
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2948 - 2956.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
A. A. Desai, R. Bolus, A. Nissenson, S. Bolus, M. D. Solomon, O. Khawar, M. Gitlin, J. Talley, and B. M. R. Spiegel
Identifying Best Practices in Dialysis Care: Results of Cognitive Interviews and a National Survey of Dialysis Providers
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1066 - 1076.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Ishani, C. A. Solid, E. D. Weinhandl, D. T. Gilbertson, R. N. Foley, and A. J. Collins
Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1682 - 1689.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Ishani, H. Guo, D. T. Gilbertson, J. Liu, S. Dunning, A. J. Collins, and R. N. Foley
Time to target haemoglobin concentration (11 g/dl) risk of hospitalization and mortality among incident dialysis patients
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2247 - 2255.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP